Cargando…

Can circulating cell free DNA be a promising marker in ovarian cancer? – a genome-scale profiling study in a single institution

BACKGROUND: Cell-free DNA (cfDNA) is emerging as a potential biomarker for the detection of ovarian cancer (OC). Recently, we reported a method based upon cfDNA whole-genome sequencing data including the nucleosome distribution (nucleosome footprinting NF), terminal signature sequence (motif), DNA f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Huimei, Zhang, Xueying, Liu, Qian, Yang, Jiaxin, Bai, Jian, Yin, Min, Cao, Dongyan, Zhang, Qingzheng, Zheng, Lu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840311/ https://www.ncbi.nlm.nih.gov/pubmed/36641505 http://dx.doi.org/10.1186/s13048-022-01068-z

Ejemplares similares

Can Circulating Cell-Free DNA or Circulating Tumor DNA Be a Promising Marker in Ovarian Cancer?
por: Yu, Ming, et al.
Publicado: (2021)

Identification of Somatic Mutations in Papanicolaou Smear DNA and Plasma Circulating Cell-Free DNA for Detection of Endometrial and Epithelial Ovarian Cancers: A Pilot Study
por: Jiang, Xuan, et al.
Publicado: (2020)

Distinct gene expression profiles associated with clinical outcomes in patients with ovarian clear cell carcinoma and high-grade serous ovarian carcinoma
por: Zhou, Huimei, et al.
Publicado: (2020)

Importance of Standard Treatment in Prognosis of Patients with Ovarian Cancer and Associated Cerebral Infarction
por: Yuan, Zhen, et al.
Publicado: (2020)

Laparoscopic vs. Open Abdominal Radical Hysterectomy for Cervical Cancer: A Single-Institution, Propensity Score Matching Study in China
por: Yuan, Zhen, et al.
Publicado: (2019)

The proteomic comparison of peripheral circulation-derived exosomes from the epithelial ovarian carcinoma (EOC) patients and non-EOC subjects
por: Peng, Peng, et al.
Publicado: (2019)

Identification of a Prognostic Signature Associated With DNA Repair Genes in Ovarian Cancer
por: Sun, Hengzi, et al.
Publicado: (2019)

The prognostic value of pretreatment CA-125 levels and CA-125 normalization in ovarian clear cell carcinoma: a two-academic-institute study
por: Bai, Huimin, et al.
Publicado: (2016)

Circulating Cell Free DNA as the Diagnostic Marker for Ovarian Cancer: A Systematic Review and Meta-Analysis
por: Zhou, Quan, et al.
Publicado: (2016)

Circulating Fascin 1 as a Promising Prognostic Marker in Adrenocortical Cancer
por: Cantini, Giulia, et al.
Publicado: (2021)

Genetic and epigenetic heterogeneity of epithelial ovarian cancer and the clinical implications for molecular targeted therapy
por: Bai, Huimin, et al.
Publicado: (2016)

Clinical Features and Prognostic Factors of Cervical Clear Cell Adenocarcinoma: A Retrospective Analysis of 74 Cases from a Tertiary Hospital
por: Liu, Yue, et al.
Publicado: (2023)

Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
por: Cheng, Xianliang, et al.
Publicado: (2017)

Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer
por: Chen, Qian, et al.
Publicado: (2019)

Impact of Adjuvant Chemotherapy on FIGO Stage I Ovarian Clear Cell Carcinoma: A Systematic Review and Meta-Analysis
por: Yin, Min, et al.
Publicado: (2022)

Uterine Adenosarcoma: A Retrospective 12-Year Single-Center Study
por: Yuan, Zhen, et al.
Publicado: (2019)

GPS-Free Localization Algorithm for Wireless Sensor Networks
por: Wang, Lei, et al.
Publicado: (2010)

Corrigendum: Uterine Adenosarcoma: A Retrospective 12-Year Single-Center Study
por: Yuan, Zhen, et al.
Publicado: (2019)

Genome-wide DNA copy number analysis in clonally expanded human ovarian cancer cells with distinct invasive/migratory capacities
por: Li, Lei, et al.
Publicado: (2017)

Could Adjuvant Chemotherapy Improve Prognosis for Cervical Cancer Patients with Elevated Pretreatment Serum Squamous-Cell Carcinoma Antigen?
por: Yuan, Zhen, et al.
Publicado: (2021)

Salvage Chemotherapy for Patients With Recurrent or Persistent Ovarian Clear Cell Carcinoma: A Retrospective Study of 164 Cases
por: Bai, Huimin, et al.
Publicado: (2015)

Ovarian yolk sac tumor in postmenopausal females: A case series and a literature review
por: Wang, Yao, et al.
Publicado: (2018)

Cell-free DNA as a promising marker for risk stratification of pulmonary embolism
por: Neto-Neves, Evandro M
Publicado: (2013)

Circulating miRNA markers show promise as new prognosticators for multiple myeloma
por: Rocci, A, et al.
Publicado: (2014)

Plasma Circulating Cell-free DNA Integrity as a Promising Biomarker for Diagnosis and Surveillance in Patients with Hepatocellular Carcinoma
por: Huang, Ao, et al.
Publicado: (2016)

Differential molecular pathway expression according to chemotherapeutic response in ovarian clear cell carcinoma
por: Yin, Min, et al.
Publicado: (2023)

The PI3K/AKT/mTOR pathway is a potential predictor of distinct invasive and migratory capacities in human ovarian cancer cell lines
por: Bai, Huimin, et al.
Publicado: (2015)

Cancer testis antigen XAGE-1 is a promising marker for the diagnosis and treatment of ovarian cancer
por: Jumaa, Maysaa Ghazi, et al.
Publicado: (2021)

Prognostic nomogram that predicts progression-free survival and overall survival of patients with ovarian clear cell carcinoma
por: Li, Jiayi, et al.
Publicado: (2022)

PIK3CA and KRAS mutations in cell free circulating DNA are useful markers for monitoring ovarian clear cell carcinoma
por: Morikawa, Asuka, et al.
Publicado: (2018)

Pattern of Venous Thromboembolism Occurrence in Gynecologic Malignancy: Incidence, Timing, and Distribution a 10-Year Retrospective Single-institutional Study
por: Ye, Shuang, et al.
Publicado: (2015)

Tumor heterogeneity in the recurrence of epithelial ovarian cancer demonstrated by polycomb group proteins
por: Gui, Ting, et al.
Publicado: (2014)

Clinical relevance of circulating cell-free microRNAs in ovarian cancer
por: Nakamura, Koji, et al.
Publicado: (2016)

Advances in circulating microRNAs as diagnostic and prognostic markers for ovarian cancer
por: Zheng, Hong, et al.
Publicado: (2013)

Circulating, cell-free DNA as a marker for exercise load in intermittent sports
por: Haller, Nils, et al.
Publicado: (2018)

Circulating cell-free DNA as a potential marker in smoke inhalation injury
por: Hayun, Yehiel, et al.
Publicado: (2019)

Characteristic and Prognostic Implication of Venous Thromboembolism in Ovarian Clear Cell Carcinoma: A 12-Year Retrospective Study
por: Ye, Shuang, et al.
Publicado: (2015)

Diagnostic potential of circulating cell-free DNA in patients needing mechanical ventilation: promises and challenges
por: Arnalich, Francisco, et al.
Publicado: (2011)

Circulating-Free DNA Analysis in Hepatocellular Carcinoma: A Promising Strategy to Improve Patients’ Management and Therapy Outcomes
por: Mezzalira, Silvia, et al.
Publicado: (2019)

Detection of OPCML methylation, a possible epigenetic marker, from free serum circulating DNA to improve the diagnosis of early-stage ovarian epithelial cancer
por: Wang, Bi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_904vapk2pplijrpjuetfd8ov07